Peter Jahrling
#20,798
Most Influential Person Now
Researcher
Peter Jahrling's AcademicInfluence.com Rankings
Peter Jahrlingbiology Degrees
Biology
#3126
World Rank
#4822
Historical Rank
Virology
#194
World Rank
#200
Historical Rank
Microbiology
#172
World Rank
#203
Historical Rank
Download Badge
Biology
Peter Jahrling's Degrees
- PhD Microbiology University of California, Davis
- Masters Microbiology University of California, Davis
- Bachelors Biology University of California, Davis
Similar Degrees You Can Earn
Why Is Peter Jahrling Influential?
(Suggest an Edit or Addition)According to Wikipedia, Peter B. Jahrling is chief of the Emerging Viral Pathogens Section of the National Institute of Allergy and Infectious Diseases. Jahrling received his PhD in medical microbiology from Cornell Medical College. He joined the military as an officer at the U.S. Army Medical Research Institute of Infectious Diseases , and remained employed as a civilian after his service. Since 2005, Jahrling has been the chief scientist of the NIAID Integrated Research Facility in Frederick, Maryland, and chief of the Emerging Viral Pathogens Section.
Peter Jahrling's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. (1999) (1148)
- Hemorrhagic fever viruses as biological weapons: medical and public health management. (2002) (671)
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses (2005) (626)
- Clinical recognition and management of patients exposed to biological warfare agents. (1997) (612)
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection (2014) (579)
- Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. (2003) (553)
- Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates (2003) (482)
- Clinical recognition and management of patients exposed to biological warfare agents. (2001) (477)
- Exotic emerging viral diseases: progress and challenges (2004) (439)
- Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations (2010) (433)
- Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox (2004) (380)
- Preliminary report: isolation of Ebola virus from monkeys imported to USA (1990) (377)
- Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys (2003) (375)
- Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus (2003) (365)
- Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. (2003) (358)
- Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. (2003) (317)
- Panmicrobial Oligonucleotide Array for Diagnosis of Infectious Diseases (2007) (309)
- Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis (2014) (304)
- Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses (2000) (300)
- Pathogenesis of experimental Ebola virus infection in guinea pigs. (1999) (299)
- Virulence differences between monkeypox virus isolates from West Africa and the Congo basin (2005) (297)
- Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection (1999) (289)
- Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. (1995) (279)
- Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. (1999) (278)
- Evaluation of candidate vaccine approaches for MERS-CoV (2015) (275)
- Differentiation of filoviruses by electron microscopy. (1995) (266)
- Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. (2002) (254)
- ELISA for the detection of antibodies to Ebola viruses. (1999) (251)
- Smallpox DNA Vaccine Protects Nonhuman Primates against Lethal Monkeypox (2004) (247)
- Evaluation in Nonhuman Primates of Vaccines against Ebola Virus (2002) (247)
- Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference (2006) (244)
- Development of a New Vaccine for the Prevention of Lassa Fever (2005) (237)
- Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys (2007) (233)
- The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis) (2001) (231)
- Viral hemorrhagic fevers. (2006) (226)
- Reorganization and expansion of the nidoviral family Arteriviridae (2015) (219)
- Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. (1996) (217)
- Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. (1980) (216)
- Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody (2002) (200)
- Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs (2006) (200)
- CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates (2011) (199)
- Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. (2000) (193)
- Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. (2014) (192)
- Human monkeypox and smallpox viruses: genomic comparison (2001) (192)
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge (2011) (190)
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates (2008) (189)
- Experimental studies of arenaviral hemorrhagic fevers. (1987) (185)
- Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. (1996) (184)
- DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. (1998) (182)
- Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment (2006) (176)
- Interferon-β 1a and SARS Coronavirus Replication (2004) (168)
- Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory (1995) (167)
- Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. (2004) (167)
- Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. (1996) (164)
- Real-time microchip PCR for detecting single-base differences in viral and human DNA. (1998) (161)
- Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. (2004) (159)
- Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies (2017) (159)
- Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses (2001) (158)
- Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. (2007) (153)
- Analysis of the Monkeypox Virus Genome (2002) (142)
- Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. (1999) (139)
- New arenavirus isolated in Brazil (1994) (139)
- Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. (1992) (139)
- Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates (1992) (132)
- Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. (2003) (132)
- Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. (1997) (120)
- Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. (2007) (120)
- Pathogenesis of Lassa virus infection in guinea pigs (1982) (119)
- The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. (2004) (117)
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species (2010) (117)
- Smallpox and pan-Orthopox Virus Detection by Real-Time 3′-Minor Groove Binder TaqMan Assays on the Roche LightCycler and the Cepheid Smart Cycler Platforms (2004) (116)
- Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. (1989) (115)
- Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain (1984) (114)
- Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. (1992) (110)
- Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants. (1997) (108)
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine (2013) (108)
- Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. (1996) (107)
- Cynomolgus Macaque as an Animal Model for Severe Acute Respiratory Syndrome (2006) (107)
- Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks. (2004) (106)
- Induction of Immune Responses in Mice and Monkeys to Ebola Virus after Immunization with Liposome-Encapsulated Irradiated Ebola Virus: Protection in Mice Requires CD4+ T Cells (2002) (106)
- Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. (1984) (106)
- Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. (1991) (105)
- Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. (1985) (103)
- Taxonomic reorganization of the family Bornaviridae (2015) (102)
- Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae (2012) (97)
- Pathogenesis of a Pichinde Virus Strain Adapted to Produce Lethal Infections in Guinea Pigs (1981) (96)
- Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. (2011) (96)
- Nomenclature- and Database-Compatible Names for the Two Ebola Virus Variants that Emerged in Guinea and the Democratic Republic of the Congo in 2014 (2014) (92)
- MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells (2018) (91)
- Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR 2 (90)
- Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. (1994) (90)
- Lymphocytic choriomeningitis virus. A neglected pathogen of man. (1992) (89)
- Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters (1984) (89)
- Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever. (1994) (89)
- Neglected filoviruses. (2016) (86)
- The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever (2007) (86)
- Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses (2011) (85)
- Real-Time PCR Assay To Detect Smallpox Virus (2003) (84)
- The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection (2017) (83)
- Endothelial Cell Permeability during Hantavirus Infection Involves Factor XII-Dependent Increased Activation of the Kallikrein-Kinin System (2013) (82)
- Evaluation of perceived threat differences posed by filovirus variants. (2011) (75)
- Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever (2018) (74)
- Marburg virus vaccines: comparing classical and new approaches. (2001) (73)
- Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. (1985) (72)
- Protection of lassa virus‐infected guinea pigs with lassa‐immune plasma of guinea pig, primate, and human origin (1983) (71)
- Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA (2013) (71)
- Field investigations of an outbreak of Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: arthropod studies. (1999) (70)
- 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012 (2016) (67)
- One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus (2016) (67)
- Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates (2010) (66)
- Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus (2015) (65)
- Patients infected with high-hazard viruses: scientific basis for infection control. (1996) (65)
- Infection of rhesus and cynomolgus macaques with a rapidly fatal SIV (SIVSMM/PBj) isolate from sooty mangabeys. (1992) (63)
- Clinical Management of Filovirus-Infected Patients (2012) (63)
- Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. (2007) (63)
- MassTag Polymerase Chain Reaction for Differential Diagnosis of Viral Hemorrhagic Fevers (2006) (63)
- Reduced evolutionary rate in reemerged Ebola virus transmission chains (2016) (61)
- Pathology of Lassa virus infection in the rhesus monkey. (1982) (61)
- Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae (2013) (60)
- Smallpox Research Activities: U.S. Interagency Collaboration, 2001 (2002) (58)
- Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus (2002) (57)
- Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease (2015) (57)
- Strengthening national preparedness for smallpox: an update. (2001) (56)
- Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay (1984) (54)
- The potential of 5′ nuclease PCR for detecting a single-base polymorphism inOrthopoxvirus (1997) (54)
- Systems Kinomics Demonstrates Congo Basin Monkeypox Virus Infection Selectively Modulates Host Cell Signaling Responses as Compared to West African Monkeypox Virus (2011) (53)
- Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names (2014) (53)
- Use of immunoelectron microscopy to show Ebola virus during the 1989 United States epizootic. (1990) (53)
- Comparative Analysis of Monkeypox Virus Infection of Cynomolgus Macaques by the Intravenous or Intrabronchial Inoculation Route (2010) (52)
- Comparative pathology of smallpox and monkeypox in man and macaques. (2013) (52)
- Ebola virus disease candidate vaccines under evaluation in clinical trials (2016) (52)
- Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs. (2003) (51)
- Towards a vaccine against Ebola virus (2003) (51)
- Pediatric Lassa fever: a review of 33 Liberian cases. (1987) (50)
- A probable endocrine basis for the depression of ketone bodies during infectious or inflammatory state in rats. (1980) (50)
- Genomic Characterization of the Genus Nairovirus (Family Bunyaviridae) (2016) (50)
- Ebola Virus Modulates Transforming Growth Factor β Signaling and Cellular Markers of Mesenchyme-Like Transition in Hepatocytes (2014) (49)
- Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A. (1999) (48)
- Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection (2017) (48)
- Ebola and Marburg viruses: pathogenesis and development of countermeasures. (2005) (48)
- Histopathology and distribution of viral antigens in hamsters infected with virulent and benign Venezuelan encephalitis viruses. (1973) (47)
- Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses. (2015) (47)
- Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures. (2018) (47)
- A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model (2017) (47)
- Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia. (1984) (46)
- Growth Curves and Clearance Rates of Virulent and Benign Venezuelan Encephalitis Viruses in Hamsters (1973) (46)
- Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection (2012) (45)
- Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease. (1996) (44)
- The International Code of Virus Classification and Nomenclature (ICVCN): proposal for text changes for improved differentiation of viral taxa and viruses (2013) (41)
- Ebolavirus Δ-Peptide Immunoadhesins Inhibit Marburgvirus and Ebolavirus Cell Entry (2011) (41)
- EXPERIMENTAL LASSA FEVER VIRUS INFECTION SUCCESSFULLY TREATED WITH RIBAVIRIN (1979) (39)
- EARLY DIAGNOSIS OF HUMAN LASSA FEVER BY ELISA DETECTION OF ANTIGEN AND ANTIBODY (1985) (39)
- Simian Hemorrhagic Fever Virus Cell Entry Is Dependent on CD163 and Uses a Clathrin-Mediated Endocytosis-Like Pathway (2014) (37)
- Virus-induced Pancreatic Disease by Venezuelan Encephalitis Virus: Alterations in Glucose Tolerance and Insulin Release (1976) (37)
- Clarification and guidance on the proper usage of virus and virus species names (2010) (37)
- Arenavirus recombination: the formation of recombinants between prototype pichinde and pichinde munchique viruses and evidence that arenavirus S RNA codes for N polypeptide. (1980) (36)
- Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells. (1975) (35)
- Virus-initiated septic shock. Acute death of Venezuelan encephalitis virus-infected hamsters. (1975) (35)
- Molar Growth Yields as Evidence for Oxidative Phosphorylation in Streptococcus faecalis Strain 10C1 (1968) (35)
- Modeling [18F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge (2015) (34)
- CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection (2014) (34)
- A proposal to change existing virus species names to non-Latinized binomials (2010) (34)
- Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin (2019) (33)
- Countermeasures to the bioterrorist threat of smallpox. (2005) (33)
- Progression of Pathogenic Events in Cynomolgus Macaques Infected with Variola Virus (2011) (33)
- Framework for Leadership and Training of Biosafety Level 4 Laboratory Workers (2008) (33)
- Molecular Characterization and Comparison of Simian Immunodeficiency Virus Isolates From Macaques, Mangabeys, and African Green Monkeys (1989) (32)
- Filoviruses and Arenaviruses (2006) (32)
- Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs (2018) (32)
- Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus (2017) (32)
- Monkeypox Virus Infection of Rhesus Macaques Induces Massive Expansion of Natural Killer Cells but Suppresses Natural Killer Cell Functions (2013) (31)
- Inhibition of Monkeypox virus replication by RNA interference (2009) (31)
- Nyamiviridae: Proposal for a new family in the order Mononegavirales (2013) (30)
- Evaluation of monkeypox disease progression by molecular imaging. (2011) (30)
- Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections. (2002) (29)
- Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus). (1996) (29)
- Nonhuman Primate Models of Ebola Virus Disease. (2017) (29)
- Two Novel Simian Arteriviruses in Captive and Wild Baboons (Papio spp.) (2014) (29)
- Heparan sulfate is an important mediator of Ebola virus infection in polarized epithelial cells (2018) (29)
- Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox. (2011) (29)
- Antiviral efficacy of pyrazofurin against selected RNA viruses. (1982) (29)
- A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence. (2012) (28)
- Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells. (1990) (28)
- The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease. (2018) (28)
- An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models. (2016) (28)
- Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells (2016) (28)
- Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease. (2011) (28)
- Middle East respiratory syndrome: obstacles and prospects for vaccine development (2015) (27)
- Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease (2018) (27)
- Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein. (2012) (27)
- Observations of equines, humans and domestic and wild vertebrates during the 1969 equine epizootic and epidemic of Venezuelan encephalitis in Guatemala. (1972) (26)
- Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus (2016) (26)
- Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. (1994) (26)
- Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B. (1977) (25)
- Association of interleukin-6 in the pathogenesis of acutely fatal SIVsmm/PBj-14 in pigtailed macaques. (1993) (25)
- Correlates to Increased Lethality of Attenuated Venezuelan Encephalitis Virus Vaccine for Immunosuppressed Hamsters (1974) (25)
- Ebola virus disease: an update on post-exposure prophylaxis. (2017) (24)
- Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters (2005) (24)
- Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays (2018) (24)
- Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy. (1991) (23)
- Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients. (1984) (23)
- Smallpox research activities (2002) (23)
- Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran (2014) (22)
- Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay. (2002) (22)
- Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys (2018) (22)
- Ecologic studies of Venezuelan encephalitis virus and isolations of Nepuyo and Patois viruses during 1968-1973 at a marsh habitat near the epicenter of the 1969 outbreak in Guatemala. (1976) (22)
- Virulence heterogeneity of a predominantly avirulent Western equine encephalitis virus population. (1976) (21)
- High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona (2017) (21)
- Molecular Imaging of Influenza and Other Emerging Respiratory Viral Infections (2011) (21)
- Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses (2012) (20)
- Immune serum increases arenavirus replication in monocytes. (1988) (20)
- Studies of the coagulation system in arenaviral hemorrhagic fever: experimental infection of strain 13 guinea pigs with Pichinde virus. (1987) (20)
- Pancreatic involvement by Venezuelan equine encephalomyelitis virus in the hamster. (1974) (20)
- Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model (2018) (20)
- Venezuelan equine encephalitis‐specific immunoglobulin responses: Live attenuated TC‐83 versus inactivated C‐84 vaccine (1992) (20)
- Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA (2018) (19)
- Differential alterations in host peripheral polymorphonuclear leukocyte chemiluminescence during the course of bacterial and viral infections. (1980) (19)
- Detection of Ebola-like viruses by immunofluorescence (1990) (19)
- Quantification of regional aerosol deposition patterns as a function of aerodynamic particle size in rhesus macaques using PET/CT imaging (2017) (19)
- Replication of hemorrhagic fever viruses in monocytic cells. (1989) (19)
- Dual-probe real-time PCR assay for detection of variola or other orthopoxviruses with dried reagents (2008) (19)
- Filovirus contamination of cell cultures. (1992) (19)
- Comparisons among members of the Venezuelan encephalitis virus complex using hydroxylapatite column chromatography. (1977) (18)
- In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus. (2018) (18)
- Interferon-b and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays (2014) (18)
- Use of Existing Diagnostic Reverse-Transcription Polymerase Chain Reaction Assays for Detection of Ebola Virus RNA in Semen. (2016) (18)
- New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model. (2018) (17)
- Enzyme-linked immunosorbent assay detection of immunoglobulins G and M to Venezuelan equine encephalomyelitis virus in vaccinated and naturally infected humans (1988) (17)
- Influenza A and methicillin-resistant Staphylococcus aureus co-infection in rhesus macaques – A model of severe pneumonia (2016) (17)
- Poxvirus Antigen Staining of Immune Cells as a Biomarker to Predict Disease Outcome in Monkeypox and Cowpox Virus Infection in Non-Human Primates (2013) (17)
- Historical Outbreaks of Simian Hemorrhagic Fever in Captive Macaques Were Caused by Distinct Arteriviruses (2015) (17)
- Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge. (1993) (17)
- Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors (2018) (16)
- Antiviral activity of the EB peptide against zoonotic poxviruses (2012) (16)
- Characterization of the Host Response to Pichinde Virus Infection in the Syrian Golden Hamster by Species-Specific Kinome Analysis* (2015) (16)
- Evidence for the involvement of sulfidopeptide leukotrienes in the pathogenesis of Pichinde virus infection in strain 13 guinea pigs. (1986) (16)
- In Vivo Activity of Amodiaquine against Ebola Virus Infection (2019) (15)
- Filovirus Pathogenesis in Nonhuman Primates (2002) (15)
- Inhibition of mouse peritoneal macrophage DNA synthesis by infection with the arenavirus Pichinde (1983) (15)
- Intrabronchial inoculation of cynomolgus macaques with cowpox virus. (2012) (15)
- The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL‐4 pathogens (2014) (15)
- Repurposing of clinically developed drugs for treatment of Middle East Respiratory Coronavirus 1 Infection (2014) (15)
- Detection and identification of Variola virus in fixed human tissue after prolonged archival storage (2004) (15)
- Lack of Effect of Lamivudine on Ebola Virus Replication (2015) (15)
- ABSL-4 Aerobiology Biosafety and Technology at the NIH/NIAID Integrated Research Facility at Fort Detrick (2014) (15)
- Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus) (2018) (14)
- Triage and management of accidental laboratory exposures to biosafety level-3 and -4 agents. (2009) (14)
- The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses (2020) (14)
- Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform. (2016) (14)
- Radioimmunoassay for Quantitation of Antibodies to Alphaviruses with Staphylococcal Protein A (1978) (14)
- Viral haemorrhagic fever in Sweden: experiences from management of a case. (1991) (14)
- Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate (2018) (14)
- Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein (2005) (14)
- Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease. (2015) (13)
- Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins. (2011) (13)
- Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone (2011) (13)
- Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. (1980) (13)
- Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol (2019) (13)
- Essentials of filoviral load quantification. (2016) (12)
- State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus. (2015) (12)
- SMALLPOX AND RELATED ORTHOPOXVIRUSES (2009) (12)
- Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples (2019) (12)
- Comparison of Multiplexed Immunofluorescence Imaging to Chromogenic Immunohistochemistry of Skin Biomarkers in Response to Monkeypox Virus Infection (2020) (12)
- Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures (2016) (12)
- Homogeneity of Venezuelan Encephalitis Virion Populations of Hamster-Virulent and Benign Strains, Including the Attenuated TC83 Vaccine (1973) (11)
- Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo (2021) (11)
- Opsonization of alphaviruses in hamsters (1983) (11)
- Evaluation of vascular clearance as a marker for virulence of alphaviruses: disassociation of rapid clearance with low virulence of venezuelan encephalitis virus strains in guinea pigs (1977) (11)
- The NIAID Integrated Research Facility at Fort Detrick (2011) (11)
- Role of Rodents and Bats in Human Viral Hemorrhagic Fevers (2013) (10)
- Genome Sequences of Simian Hemorrhagic Fever Virus Variant NIH LVR42-0/M6941 Isolates (Arteriviridae: Arterivirus) (2014) (10)
- Divergent Simian Arteriviruses Cause Simian Hemorrhagic Fever of Differing Severities in Macaques (2016) (10)
- Virologic investigation of a case of suspected haemorrhagic fever. (1994) (10)
- Molecular Aspects of the Antiviral Activity of Ribavirin on Venezuelan Equine Encephalomyelitis Virus (1980) (10)
- Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development (2005) (10)
- Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine. (2015) (10)
- Multiple Genetic Differences between the Monkeypox and Variola Viruses (2002) (9)
- Countermeasures to the Reemergence of Smallpox Virus as an Agent of Bioterrorism (2000) (9)
- Pathogenesis of a Venezuelan encephalitis virus strain lethal for adult white rats (1978) (9)
- Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques (2013) (9)
- Use of immunoelectron microscopy to demonstrate Francisella tularensis (1993) (9)
- Receptor interaction between eastern equine encephalitis virus and chicken embryo fibroblasts (1977) (9)
- Correlation between virus-cell receptor properties of alphavirusesin vitro and virulencein vivo (2005) (8)
- [18F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor of Disease Outcome in the Nonhuman Primate Model of Monkeypox Virus Infection (2017) (8)
- Interferon-&bgr; and Interferon-&ggr; Are Weak Inhibitors of Ebola Virus in Cell-Based Assays (2017) (8)
- The International Code of Virus Classification and Nomenclature (ICVCN): proposal to delete Rule 3.41 (2012) (8)
- Interference between virulent and vaccine strains of Venezuelan encephalitis virus in mixed infections of hamsters. (1975) (8)
- Chromatographic Separations of Alphavirus Strains by Hydroxylapatite (1977) (8)
- Characterization of the binding of the TC-83 strain of Venezuelan Equine encephalomyelitis virus to BW-J-M, a mouse macrophage-like cell line. (1983) (7)
- Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures. (2016) (7)
- Host metabolic alterations during Venezuelan equine encephalitis in the rat. (1978) (7)
- Comparison of respiratory inductive plethysmography versus head-out plethysmography for anesthetized nonhuman primates in an animal biosafety level 4 facility (2016) (7)
- Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model (2020) (7)
- The Human Sodium Iodide Symporter as a Reporter Gene for Studying Middle East Respiratory Syndrome Coronavirus Pathogenesis (2018) (7)
- Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission. (1992) (7)
- Potential Impact of a 2-Person Security Rule on BioSafety Level 4 Laboratory Workers (2009) (6)
- The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection. (2018) (6)
- Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory Mice (2019) (6)
- Nonhuman Transferrin Receptor 1 Is an Efficient Cell Entry Receptor for Ocozocoautla de Espinosa Virus (2013) (6)
- Viral Hemorrhagic Fevers: History and Definitions (2013) (6)
- Dynamics of oliveros virus infection in rodents in central Argentina. (2007) (6)
- Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices. (2016) (5)
- Specific Detection of Two Divergent Simian Arteriviruses Using RNAscope In Situ Hybridization (2016) (5)
- Microbe: Are We Ready for the Next Plague? (2005) (5)
- Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease. (2016) (5)
- Guidelines for the Prevention of Simian Immunodeficiency Virus Infection in Laboratory Workers and Animal Handlers (1989) (5)
- Chemotherapy for 'exotic' RNA viruses. (1985) (5)
- Generation and characterization of large-particle aerosols using a center flow tangential aerosol generator with a non-human-primate, head-only aerosol chamber (2015) (5)
- Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology. (2016) (4)
- Systems kinomics for characterizing host responses to high‐consequence pathogens at the NIH/NIAID Integrated Research Facility‐Frederick (2014) (4)
- Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever (2018) (4)
- Filoviruses infect rhesus macaque synoviocytes in vivo and primary human synoviocytes in vitro. (2020) (4)
- Preclinical Imaging in BSL-3 and BSL-4 Environments: Imaging Pathophysiology of Highly Pathogenic Infectious Diseases (2014) (4)
- Discovery of Lanama Virus, a Distinct Member of Species Kunsagivirus C (Picornavirales: Picornaviridae), in Wild Vervet Monkeys (Chlorocebus pygerythrus) (2020) (4)
- Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae (2012) (3)
- Ebola virus, but not Marburg virus, replicates efficiently and without required adaptation in snake cells (2018) (3)
- Enterotoxic Shock in Rhesus Monkeys: The Role of Selected Bloodborne Factors (1978) (3)
- Significance of hemodynamic changes in four cardiac chambers of guinea pigs infected with Pichinde virus (1998) (3)
- Variola virus archives: a new century, a new approach (2014) (3)
- MolarGrowth Yields asEvidence forOxidative Phosphorylation inStreptococcus faecalis Strain lOCIh (1968) (3)
- Sequence of Reston Virus Isolate AZ-1435, an Ebolavirus Isolate Obtained during the 1989–1990 Reston Virus Epizootic in the United States (2017) (3)
- Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA (2013) (2)
- Viral Haemorrhagic Fevers, Perspectives in Medical Virology, Volume 11 (2005) (2)
- Acute Late-Stage Myocarditis in the Crab-Eating Macaque Model of Hemorrhagic Smallpox (2021) (2)
- The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by 18F-FDG-PET (2014) (2)
- Resolving power in a practical application of preparative sodium dodecyl sulfate polyacrylamide gel electrophoresis: preparation of Eastern encephalitis virus proteins. (1977) (2)
- Expanded Histopathology and Tropism of Ebola Virus in the Rhesus Macaque Model: Potential for Sexual Transmission, Altered Adrenomedullary Hormone Production and Early Viral Replication in liver. (2021) (2)
- Within-Host Evolution of Simian Arteriviruses in Crab-Eating Macaques (2016) (2)
- Development and Characterization of a cDNA-Launch Recombinant Simian Hemorrhagic Fever Virus Expressing Enhanced Green Fluorescent Protein: ORF 2b’ Is Not Required for In Vitro Virus Replication (2021) (2)
- “Venezuelan” Hemorrhagic Fever (2013) (2)
- Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections (2020) (2)
- Clinical Characterization of Host Response to Simian Hemorrhagic Fever Virus Infection in Permissive and Refractory Hosts: A Model for Determining Mechanisms of VHF Pathogenesis (2018) (2)
- CHAPTER 73 – Filovirus Infections (2011) (2)
- Vascular clearance of Venezuelan equine encephalomyelitis viruses as a correlate to virulence for rhesus monkeys (2005) (2)
- Arenaviruses: Hemorrhagic Fevers (2012) (2)
- Create a family named Nyamiviridae, with 1 genus and 3 species, in the order Mononegavirales (2013) (1)
- Reorganization and expansion of the nidoviral family Arteriviridae (2015) (1)
- General Disease Pathology in Filoviral and Arenaviral Infections (2013) (1)
- Ebola Virus Modulates Transforming Growth Factor-β Signaling and Cellular Markers of 1 (2014) (1)
- Inhibition of Monkeypox virus replication by RNAi (2010) (1)
- The Role of Viral Protein Phosphorylation During Filovirus Infection (2015) (1)
- Genomic characterization of serial-passaged Ebola virus in a boa constrictor cell line (2016) (1)
- Candidate Medical Countermeasures Targeting Ebola Virus Cell Entry (2017) (1)
- Antiviral activity of the EB peptide against zoonotic poxviruses (2012) (1)
- Animal Models of Ebolavirus Infection. (2017) (1)
- Chapter 29: Viral Hemorrhagic Fevers (1996) (1)
- Laboratory studies on the effect of gamma radiation on Erwinia amylovora survival on apple fruit (1986) (1)
- Filoviruses: Hemorrhagic Fevers (2012) (1)
- Bolivian hemorrhagic fever (2013) (1)
- EnzymeImmunosorbent AssayforEbolaVirusAntigens inTissues ofInfected Primates (1992) (0)
- 1 Outbreaks of Ebolavirus Hemorrhagic Fever Virus Year ( s ) Location Cases ( % Case Fatality ) Epidemiology Remarks (2014) (0)
- Bases for cross-protective relationships among old-world arenaviruses (1985) (0)
- Computed Tomography Imaging for Monitoring of Marburg Virus Disease: a Nonhuman Primate Proof-Of-Concept Study (2023) (0)
- neutralizing antibody and Lassa virus strain. cynomolgus monkeys: importance of Passive antibody therapy of Lassa fever in (2013) (0)
- Nyamiviridae: Proposal for a new family in the order Mononegavirales (2013) (0)
- The International Code of Virus Classification and Nomenclature (ICVCN): proposal to delete Rule 3.41 (2012) (0)
- Taxonomic reorganization of the family Bornaviridae (2014) (0)
- Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae (2013) (0)
- Mechanism of Action of Ribavirin: An Antiviral Drug of Military Importance, (1980) (0)
- Protective Efficacies ofLiveAttenuated andFormaldehyde- Inactivated Venezuelan EquineEncephalitis VirusVaccines Against Aerosol Challenge inHamsters (1984) (0)
- DIFFERENTIAL EFFECTS OF BACTERIAL AND VIRAL INFECTIONS ON GRANULOCYTE CHEMILUMINESCENCE (CL) (1981) (0)
- The International Code of Virus Classification and Nomenclature (ICVCN): proposal for text changes for improved differentiation of viral taxa and viruses (2013) (0)
- 1976 USAMRIID Planning Session with the Ad Hoc Study Group for Special Infectious Disease Problems, 18-19 November 1976. (1977) (0)
- Comparison of the protecti v e efficacy of DNA and baculo v irus-deri v ed protein v accines for EBOLA v irus in guinea pigs (2003) (0)
- Overlooking the importance of immunoassays - Authors' reply. (2016) (0)
- Ebolavirus (cid:1) -Peptide Immunoadhesins Inhibit Marburgvirus and Ebolavirus Cell Entry (cid:1) (2011) (0)
- Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model (2018) (0)
- Book Review (2010) (0)
- Heparan sulfate is an important mediator of Ebola virus infection in polarized epithelial cells (2018) (0)
- Viral hemorrbagic fevers (2006) (0)
- Evaluation of bone marrow in cowpox virus infection in cynomolgus macaques (VIR1P.1127) (2015) (0)
- High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona (2017) (0)
- Pathogens Causing Viral Hemorrhagic Fevers (2011) (0)
- Pro-inflammatory cytokine production by activated monocytes and macrophages in response to cowpox virus infection in cynomologus macaques (VIR9P.1144) (2015) (0)
- THE EFFECTS OF HEMORRHAGIC FEVER VIRUS INFECTION OF ENDOTHELIAL CELLS (1987) (0)
- Viral Hemorrhagic FeversOpinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Department of the Army, U.S. Department of Defense or the Department of Health and Human Services. (2010) (0)
- THE JOURNAL OF INFECTIOUS DISEASES (0)
- Effect of Ribavirin on Protein and RNA Synthesis in VEE Virus-Infected Cells. (1980) (0)
- A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model (2017) (0)
- Pathogenesis of Ebola Virus Infection in Nonhuman Primates (2003) (0)
- Towards a vaccine against Ebola virus , Expert Review of Vaccines (2003) (0)
- Monkeypox virus infection of rhesus macaques induces massive expansion of NK cells, but suppresses NK cell function (P4369) (2013) (0)
- Mice Help Unravel Mystery of Spanish Flu Virulence (2004) (0)
- Hemorrhagic Fever-Causing Mammarenaviruses Chapter 21 HEMORRHAGIC FEVER-CAUSING MAMMARENAVIRUSES (2018) (0)
- Author Correction: Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model (2019) (0)
- The Antiviral Potential of ERK / MAPK and PI 3 K / AKT / mTOR Signaling Modulation 1 for MERS-CoV Infection as Identified by Temporal Kinome Analysis 2 3 4 Running Title : Kinome analysis of MERS-CoV infection 5 6 (2014) (0)
- Smoke-free policies: cleaning the air with money to spare (2014) (0)
- Marburg Virus Disease (2013) (0)
- Commentary on Dr. Alan Zelicoff's Analysis of the Aralsk Outbreak (No. 4) (2003) (0)
- Using Less, Staying Clean. (2002) (0)
- CHAPTER 57 – Smallpox and Related Orthopoxviral Infections (2011) (0)
This paper list is powered by the following services:
Other Resources About Peter Jahrling
What Schools Are Affiliated With Peter Jahrling?
Peter Jahrling is affiliated with the following schools:
